A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern Africa.
Palliative care
actual place of death
cancer patients
preferred place of death
prospective study
sub-Saharan Africa
Journal
Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
27
09
2018
revised:
22
01
2019
accepted:
23
01
2019
pubmed:
2
2
2019
medline:
10
9
2020
entrez:
2
2
2019
Statut:
ppublish
Résumé
Identifying factors that affect terminally ill patients' preferences for and actual place of death may assist patients to die wherever they wish. The objective of this study was to investigate factors associated with preferred and actual place of death for cancer patients in Johannesburg, South Africa. In a prospective cohort study at a tertiary hospital in Johannesburg, South Africa, adult patients with advanced cancer and their caregivers were enrolled from 2016 to 2018. Study nurses interviewed the patients at enrollment and conducted postmortem interviews with the caregivers. Of 324 patients enrolled, 191 died during follow-up. Preferred place of death was home for 127 (66.4%) and a facility for 64 (33.5%) patients; 91 (47.6%) patients died in their preferred setting, with a kappa value of congruence of 0.016 (95% CI = -0.107, 0.139). Factors associated with congruence were increasing age (odds ratio [OR]: 1.03, 95% CI: 1.00-1.05), use of morphine (OR: 1.87, 95% CI: 1.04-3.36), and wanting to die at home (OR: 0.44, 95% CI: 0.24-0.82). Dying at home was associated with increasing age (OR 1.03, 95% CI 1.00-1.05) and with the patient wishing to have family and/or friends present at death (OR 6.73, 95% CI 2.97-15.30). Most patients preferred to die at home, but most died in hospital and fewer than half died in their preferred setting. Further research on modifiable factors, such as effective communication, access to palliative care and morphine, may ensure that more cancer patients in South Africa die wherever they wish.
Identifiants
pubmed: 30708125
pii: S0885-3924(19)30047-8
doi: 10.1016/j.jpainsymman.2019.01.014
pmc: PMC6531674
mid: NIHMS1029446
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
923-932Subventions
Organisme : NCI NIH HHS
ID : P30 CA013696
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA192627
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197730
Pays : United States
Informations de copyright
Copyright © 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
Références
J Palliat Care. 2003 Winter;19(4):230-7
pubmed: 14959592
BMJ. 2006 Mar 4;332(7540):515-21
pubmed: 16467346
J Epidemiol Community Health. 2006 May;60(5):412-6
pubmed: 16614331
Support Care Cancer. 2007 Mar;15(3):243-9
pubmed: 17021856
Palliat Med. 2008 Oct;22(7):787-95
pubmed: 18755830
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Palliat Med. 2009 Sep;23(6):482-90
pubmed: 19494055
Health Qual Life Outcomes. 2010 Jan 25;8:10
pubmed: 20100332
J Clin Oncol. 2011 Mar 20;29(9):1159-67
pubmed: 21343566
BMC Palliat Care. 2011 Mar 09;10:6
pubmed: 21388538
J Clin Oncol. 2012 Aug 1;30(22):2783-7
pubmed: 22734023
J Pain Symptom Manage. 2013 Apr;45(4):746-52
pubmed: 23017619
BMC Palliat Care. 2013 Mar 26;12:14
pubmed: 23530478
J Pain Symptom Manage. 2014 Mar;47(3):620-30
pubmed: 23870841
BMC Palliat Care. 2014 Feb 15;13(1):4
pubmed: 24529217
PLoS One. 2014 Apr 08;9(4):e93762
pubmed: 24714736
Am J Hosp Palliat Care. 2015 Dec;32(8):835-40
pubmed: 25007797
Indian J Palliat Care. 2014 May;20(2):101-6
pubmed: 25125864
Br J Cancer. 2015 Nov 3;113(9):1397-404
pubmed: 26325102
BMJ Qual Improv Rep. 2013 Aug 21;2(1):null
pubmed: 26734208
J Clin Oncol. 2016 Jul 10;34(20):2398-403
pubmed: 27217454
SSM Popul Health. 2017 Feb 02;3:227-235
pubmed: 29349220
J Pain Symptom Manage. 2018 Jul;56(1):98-106
pubmed: 29604380
J Glob Oncol. 2018 Sep;4:1-9
pubmed: 30241251